Abstract
Amorphous solid dispersions can improve the solubility and dissolution performance of poorly soluble drugs. However, residual crystallinity can adversely affect the dissolution in formulations design to be in amorphous state. This study aimed to develop near-infrared spectroscopy (NIRS) as a potential real-time in-line approach to detect residual crystallinity and carbamazepine (CBZ) polymorphs in its Soluplus® dispersions. Our results show that different CBZ-Soluplus® ratios and processing techniques can affect the polymorphism of CBZ. CBZ Form II and III appeared in 30% and 50% CBZ solvent casting dispersions, respectively, while a mixture of Form I and III was detected in 50% CBZ hot-melt extruded samples. All the solid-state forms of CBZ were confirmed by X-ray diffraction (XRD). Our results showed that NIR was able to detect residual crystalline CBZ and distinguish the CBZ Form III from other polymorphs using the second derivative of the spectra.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
